Carelabs Co.Ltd (263700) - Total Assets
Based on the latest financial reports, Carelabs Co.Ltd (263700) holds total assets worth ₩105.15 Billion KRW (≈ $71.26 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Carelabs Co.Ltd (263700) shareholders funds for net asset value and shareholders' equity analysis.
Carelabs Co.Ltd - Total Assets Trend (2016–2024)
This chart illustrates how Carelabs Co.Ltd's total assets have evolved over time, based on quarterly financial data.
Carelabs Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Carelabs Co.Ltd's total assets of ₩105.15 Billion consist of 69.1% current assets and 30.9% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 21.4% |
| Accounts Receivable | ₩4.96 Billion | 3.5% |
| Inventory | ₩34.53 Million | 0.0% |
| Property, Plant & Equipment | ₩20.01 Billion | 14.0% |
| Intangible Assets | ₩4.26 Billion | 3.0% |
| Goodwill | ₩8.43 Billion | 5.9% |
Asset Composition Trend (2016–2024)
This chart illustrates how Carelabs Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 263700 market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Carelabs Co.Ltd's current assets represent 69.1% of total assets in 2024, an increase from 36.4% in 2016.
- Cash Position: Cash and equivalents constituted 21.4% of total assets in 2024, up from 20.8% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, a decrease from 56.0% in 2016.
- Asset Diversification: The largest asset category is property, plant & equipment at 14.0% of total assets.
Carelabs Co.Ltd Competitors by Total Assets
Key competitors of Carelabs Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Alcidion Group Ltd
AU:ALC
|
Australia | AU$115.63 Million |
|
DocCheck AG
XETRA:AJ91
|
Germany | €53.98 Million |
|
TRELLUS HEALTH LS -0006
F:85Q
|
Germany | €9.22 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$23.68 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
|
Oneview Healthcare Plc
AU:ONE
|
Australia | AU$15.49 Million |
Carelabs Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.29 | 1.51 | 4.19 |
| Quick Ratio | 2.29 | 1.51 | 4.16 |
| Cash Ratio | 0.00 | 0.48 | 0.00 |
| Working Capital | ₩31.27 Billion | ₩34.75 Billion | ₩47.03 Billion |
Carelabs Co.Ltd - Advanced Valuation Insights
This section examines the relationship between Carelabs Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.80 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -11.7% |
| Total Assets | ₩143.26 Billion |
| Market Capitalization | $34.77 Million USD |
Valuation Analysis
Below Book Valuation: The market values Carelabs Co.Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Carelabs Co.Ltd's assets decreased by 11.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Carelabs Co.Ltd (2016–2024)
The table below shows the annual total assets of Carelabs Co.Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩143.26 Billion ≈ $97.08 Million |
-11.68% |
| 2023-12-31 | ₩162.20 Billion ≈ $109.92 Million |
-10.22% |
| 2022-12-31 | ₩180.66 Billion ≈ $122.43 Million |
-9.04% |
| 2021-12-31 | ₩198.60 Billion ≈ $134.59 Million |
+50.53% |
| 2020-12-31 | ₩131.93 Billion ≈ $89.41 Million |
+3.79% |
| 2019-12-31 | ₩127.11 Billion ≈ $86.14 Million |
+2.01% |
| 2018-12-31 | ₩124.61 Billion ≈ $84.45 Million |
+212.93% |
| 2017-12-31 | ₩39.82 Billion ≈ $26.99 Million |
+151.09% |
| 2016-12-31 | ₩15.86 Billion ≈ $10.75 Million |
-- |
About Carelabs Co.Ltd
Carelabs Co.,Ltd operates as a healthcare and beauty care platform company in South Korea. The company offers healthcare IT services, such as hospital information services, hospital customer management software, and digital marketing solutions. It provides BABITALK, a plastic surgery information platform; Medijob, which provides human resources to hospitals; VIBE RC, a digital marketing platform;… Read more